BASF Ludwigshafen Plant Explosion Leaves Three Dead
An explosion and fire at a BASF plant in Ludwigshafen that left two dead resulted from work on a pipeline containing ethylene and propylene product.
*Update on Oct. 19, 2016
An explosion and fire in the BASF Ludwigshafen, Germany site was extinguished on Oct. 17, 2016. The fire resulted during work on a pipeline containing ethylene and propylene product. The company reported that the fire left two BASF firefighters, and an unidentified person dead. In a statement, BASF said eight people were seriously injured, 17 suffered from minor injuries, and one person is still missing.
The BASF fire department and the Ludwigshafen fire department are both on scene performing cooling and safety measures. The company reported that as of Oct. 18, the raw material supply was still interrupted and steamcrackers remained shut down. Approximately 20 other plants were shut down or partially running. BASF has set up an information center for the public at gate 11. The company said it will closely support the relevant authorities in investigating the cause of the accident.
“We are deeply saddened that two employees have died. As fire fighters, they were devoted to saving lives. Our deepest sympathy lies with the affected people and their families,” Margret Suckale, member of the Board and Industrial Relations Director at BASF SE, said in a statement. The company has been posting updates on both their Facebook page, Twitter, and website.
Source: BASF
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
